home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

bluebird bio, Inc. - Common Stock (NQ:BLUE)

4.970 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about bluebird bio, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street ↗

September 12, 2023

Find out why analysts have such high expectations for these stocks.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

bluebird bio Announces September Investor Events

September 05, 2023

From bluebird bio, Inc.

Via Business Wire

1 Beaten-Down Stock That Could Soar by 89%, According to Wall Street ↗

August 05, 2023

Are you feeling brave?

Via The Motley Fool

Why Bluebird Bio Stock Is Taking Flight Today ↗

July 19, 2023

An analyst upgrade is fueling a double-digit rise in the biotech's shares today.

Via The Motley Fool

Is Bluebird Bio a Bargain Buy in September? ↗

August 29, 2023

With multiple near-term growth catalysts in play, expectations are already high.

Via The Motley Fool

Wall Street Thinks This Tiny Biotech Company Could Soar Soon ↗

August 28, 2023

An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle.

Via The Motley Fool

1 Beaten-Down Growth Stock You'd Regret Not Buying on the Dip, According to Wall Street ↗

August 24, 2023

Is this stock a value buy or a value trap?

Via The Motley Fool

7 Very Oversold Nasdaq Stocks to Buy Right Now ↗

August 23, 2023

The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq oversold Nasdaq investment opportunities.

Via InvestorPlace

bluebird bio Confirms That FDA Has Communicated That Advisory Committee Meeting Will Not Be Scheduled for lovo-cel Gene Therapy for Sickle Cell Disease

August 16, 2023

From bluebird bio, Inc.

Via Business Wire

bluebird bio Inc. (NASDAQ: BLUE) Leading the Way in Wednesday Trading Based on Percentage Gain

July 19, 2023

Via Investor Brand Network

Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗

August 08, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...

Via Benzinga

bluebird bio Reports Second Quarter 2023 Financial Results and Highlights Operational Progress

August 08, 2023

From bluebird bio, Inc.

Via Business Wire

2 Magnificent Growth Stocks I'm Buying Hand Over Fist Right Now ↗

August 08, 2023

These two growth stocks could deliver stellar returns over the long term.

Via The Motley Fool

3 Stocks to Buy for Lottery Jackpot Style Returns ↗

July 27, 2023

Although you can try your hand at the lottery, your odds of success are probably far better with stocks with high returns.

Via InvestorPlace

bluebird bio to Host Second Quarter 2023 Financial Results Conference Call and Provide Commercial Update

July 25, 2023

From bluebird bio, Inc.

Via Business Wire

3 Small-Cap Stocks That Could Be Big-Time Winners ↗

July 22, 2023

These stocks come with significant risks. But they could generate huge returns over time.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 21, 2023

Via Benzinga

Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 19, 2023

Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 19, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗

July 19, 2023

Via Benzinga

AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday ↗

July 19, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 19, 2023

Via Benzinga

Why bluebird bio Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

July 19, 2023

Gainers 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares surged 23.6% to $2.99 in pre-market trading after dipping 21% on Tuesday.

Via Benzinga

Cisco To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

July 19, 2023

Wedbush boosted the price target for Domino's Pizza, Inc. (NYSE: DPZ) from $365 to $430. Wedbush analyst Nick Setyan maintained an Outperform rating. Domino's shares rose 0.7% to close at $392.29 on...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 19, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday!

Via InvestorPlace

Down 51% in 2023, Here's Why Bluebird Bio Stock Could Soon Double, Says Wall Street ↗

June 30, 2023

This company could soon commercialize its third gene therapy.

Via The Motley Fool

This 1 Problem Could Sink at Least 4 Gene-Editing Stocks ↗

June 29, 2023

Reaching profitability could be harder than investors expect.

Via The Motley Fool

Is Bluebird Bio Stock a Buy Now? ↗

June 29, 2023

If the company can pull off a comeback, investors who get in now will see incredible returns. But how likely is a comeback?

Via The Motley Fool

bluebird bio Announces FDA Priority Review of the Biologics License Application for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events

June 21, 2023

From bluebird bio, Inc.

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com